Skip to main content

Selection of Treatment for Patients with Early Stage Non-Small Cell Lung Cancer in a Multidisciplinary Thoracic Oncology Program

  • Chapter
Treating Tumors that Move with Respiration

Abstract

Lung cancer is the leading cause of cancer mortality in men and women. More than 170,000 Americans receive a diagnosis of lung cancer annually and the majority of them die of the disease [1]. There is considerable interest in improving treatment for lung cancer given its high impact on society. More than 80% of patients with lung cancer have non-small cell carcinoma (NSCLC). Surgery is the mainstay of treatment for patients with early stage NSCLC and results in cure of about 60–80% of patients with stage I (T1-2N0) disease [2]–[5].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106–130.

    Article  PubMed  Google Scholar 

  2. Dominioni L, Imperatori A, Rovera F, et al. Stage I nonsmall cell lung carcinoma: analysis of survival and implications for screening. Cancer 2000;89:2334–2344.

    Article  PubMed  CAS  Google Scholar 

  3. Flehinger BJ, Kimmel M, Melamed MR. The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest 1992;101:1013–1018.

    PubMed  CAS  Google Scholar 

  4. Gharagozloo F, Tempesta B, Margolis M, et al. Video-assisted thoracic surgery lobectomy for stage I lung cancer. Ann Thorac Surg 2003;76:1009–1014; discussion 1014–1005.

    Article  PubMed  Google Scholar 

  5. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710–1717.

    PubMed  CAS  Google Scholar 

  6. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615–622; discussion 622–613.

    Article  PubMed  CAS  Google Scholar 

  7. Kaskowitz L, Graham MV, Emami B, et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993;27:517–523.

    PubMed  CAS  Google Scholar 

  8. Sibley GS, Jamieson TA, Marks LB, et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 1998;40:149–154.

    Article  PubMed  CAS  Google Scholar 

  9. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833–4839.

    Article  PubMed  Google Scholar 

  10. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623–1631.

    Article  PubMed  Google Scholar 

  11. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427–1431.

    Article  PubMed  Google Scholar 

  12. Wulf J, Baier K, Mueller G, et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 2005;77:83–87.

    Article  PubMed  Google Scholar 

  13. Le Q-T, Loo BW, Ho A, et al. Results of a phase I doseescalation study using single-fraction stereotactic radiotherapy for lung tumors. Journal of Thoracic Oncology · Volume, Number, 2006;1:802–809.

    Google Scholar 

  14. Nuyttens JJ, Prevost JB, Praag J, et al. Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results. Acta Oncol 2006;45:961–965.

    Article  PubMed  CAS  Google Scholar 

  15. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1–8.

    Article  PubMed  CAS  Google Scholar 

  16. Goldberg SN, Gazelle GS, Compton cc, et al. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 1995;2:776–784.

    Article  PubMed  CAS  Google Scholar 

  17. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005;129:639–644.

    Article  PubMed  Google Scholar 

  18. Herrera LJ, Fernando HC, Perry Y, et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg 2003;125:929–937.

    Article  PubMed  Google Scholar 

  19. Hiraki T, Sakurai J, Tsuda T, et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors. Cancer 2006;107:2873–2880.

    Article  PubMed  Google Scholar 

  20. Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004;15:463–470.

    PubMed  Google Scholar 

  21. Lee JM, Jin Gy, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004;230:125–134.

    Article  PubMed  Google Scholar 

  22. Grieco CA, Simon CJ, Mayo-Smith WW, et al. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 2006;17:1117–1124.

    Article  PubMed  Google Scholar 

  23. Kagan AR. The multidisciplinary clinic. Int J Radiat Oncol Biol Phys 2005;61:967–968.

    Article  PubMed  Google Scholar 

  24. Forrest LM, McMillan DC, McArdle CS, et al. An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable nonsmall-cell lung cancer. Br J Cancer 2005;93:977–978.

    Article  PubMed  CAS  Google Scholar 

  25. Junor EJ, Hole DJ, Gillis CR. Management of ovarian cancer: referral to a multidisciplinary team matters. Br J Cancer 1994;70:363–370.

    PubMed  CAS  Google Scholar 

  26. Boyle FM, Robinson E, Dunn SM, et al. Multidisciplinary care in cancer: the fellowship of the ring. J Clin Oncol 2005;23:916–920.

    Article  PubMed  Google Scholar 

  27. Hall P, Weaver L. Interdisciplinary education and teamwork: a long and winding road. Med Educ 2001;35:867–875.

    Article  PubMed  CAS  Google Scholar 

  28. Society BT, Britain SoCSoG, Party IW. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001;56:89–108.

    Article  Google Scholar 

  29. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120–129.

    Article  PubMed  CAS  Google Scholar 

  30. Yoon H-E. Wide wedge resection for lung cancer ≤ 1 cm. American Society of Clinical Oncology; 2004. p. abstract #7 7247.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Berman, S.M. et al. (2007). Selection of Treatment for Patients with Early Stage Non-Small Cell Lung Cancer in a Multidisciplinary Thoracic Oncology Program. In: Urschel, H.C., Kresl, J.J., Luketich, J.D., Papiez, L., Timmerman, R.D., Schulz, R.A. (eds) Treating Tumors that Move with Respiration. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69886-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69886-9_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69885-2

  • Online ISBN: 978-3-540-69886-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics